Kaboom! CR Pharma listing fetches $1.8bn
China Resources Pharmaceutical Group priced its Hong Kong IPO near the middle of expectations on Friday morning, raising HK$14bn ($1.8bn) after investors stormed into the trade.
Unlock this article.
The content you are trying to view is exclusive to our subscribers.
To unlock this article:
- ✔ 4,000 annual insights
- ✔ 700+ notes and long-form analyses
- ✔ 4 capital markets databases
- ✔ Daily newsletters across markets and asset classes
- ✔ 2 weekly podcasts